The N-cadherin cytoplasmic domain confers anchorage-independent growth and the loss of contact inhibition

被引:6
|
作者
Ozawa, Masayuki [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
关键词
BETA-CATENIN; HIPPO PATHWAY; TUMOR-SUPPRESSOR; CELL-GROWTH; GENE-EXPRESSION; YAP ONCOPROTEIN; PROLIFERATION; ADHESION; PROTEIN; CANCER;
D O I
10.1038/srep15368
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor growth is characterized by anchorage independence and the loss of contact inhibition. Previously, we showed that either a red fluorescent protein (DsRed)-tagged N-cadherin or E-cadherin cytoplasmic domain (DNCT or DECT) could function as a dominant negative inhibitor by blocking the cell surface localization of endogenous E-cadherin and inducing cell dissociation. Here, we show that expression of DNCT abrogated contact inhibition of proliferation and conferred anchorage-independent growth. DNCT expression induced the relocation of the tumor suppressor Merlin from the cell surface to intracellular compartments. Although DNCT expression induced redistribution of TAZ from the cytoplasm to the nucleus, YAP/TAZ signaling was not activated. An E-cadherin-alpha-catenin chimera that functions as a beta-catenin-independent cell adhesion molecule restored contact inhibition and anchorage-dependency of growth. Addition of the SV40 large T antigen nuclear localization signal reversed the effects of DNCT expression, indicating that DNCT functioned outside of the nucleus.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
    Kristy K. Ward
    Isabelle Tancioni
    Christine Lawson
    Nichol L. G. Miller
    Christine Jean
    Xiao Lei Chen
    Sean Uryu
    Josephine Kim
    David Tarin
    Dwayne G. Stupack
    Steven C. Plaxe
    David D. Schlaepfer
    Clinical & Experimental Metastasis, 2013, 30 : 579 - 594
  • [32] Inhibition of protein kinase Cα enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2
    Huigsloot, M
    Tijdens, RB
    Van de Water, B
    MOLECULAR PHARMACOLOGY, 2003, 64 (04) : 965 - 973
  • [33] Genetic and pharmacological FAK inhibition disrupt a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth
    Tancioni, Isabelle
    Uryu, Sean
    Sulzmaier, Florian
    Shah, Nina
    Lawson, Christine
    Miller, Nichol L. G.
    Jean, Christine
    Chen, Xiao Lei
    Ward, Kristy K.
    Schlaepfer, David D.
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
    Ward, Kristy K.
    Tancioni, Isabelle
    Lawson, Christine
    Miller, Nichol L. G.
    Jean, Christine
    Chen, Xiao Lei
    Uryu, Sean
    Kim, Josephine
    Tarin, David
    Stupack, Dwayne G.
    Plaxe, Steven C.
    Schlaepfer, David D.
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (05) : 579 - 594
  • [35] CYTOPLASMIC PH AND ANCHORAGE-INDEPENDENT GROWTH INDUCED BY V-KI-RAS, V-SRC OR POLYOMA MIDDLE-T
    SCHWARTZ, MA
    RUPP, EE
    FRANGIONI, JV
    LECHENE, CP
    ONCOGENE, 1990, 5 (01) : 55 - 58
  • [36] Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain
    Park, Jung-Eun
    Kim, Tae-Sung
    Kim, Bo Yeon
    Lee, Kyung S.
    CELL CYCLE, 2015, 14 (22) : 3624 - 3634
  • [37] GAIN-OF-FUNCTION tGLI1 TRANSCRIPTION FACTOR AUGMENTS ANCHORAGE-INDEPENDENT GROWTH OF MEDULLOBLASTOMA CELLS AND CONFERS THEIR RESISTANCE TO SMO INHIBITORS
    Cao, Xinyu
    Zhu, Hu
    Bigner, Darell
    Ali-Osman, Francis
    Lo, Hui-Wen
    NEURO-ONCOLOGY, 2011, 13 : I9 - I9
  • [38] ERK Activation and Nuclear Signaling Induced by the Loss of Cell/Matrix Adhesion Stimulates Anchorage-Independent Growth of Ovarian Cancer Cells
    A-Ayoubi, Adnan
    Tarcsafalvi, Adel
    Zheng, Hui
    Sakati, Wayne
    Eblen, Scott T.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (03) : 875 - 884
  • [39] Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+breast cancer cells
    DiScala, Molly
    Najor, Matthew S.
    Yung, Timothy
    Morgan, Deri
    Abukhdeir, Abde M.
    Cobleigh, Melody A.
    PLOS ONE, 2020, 15 (06):
  • [40] Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain
    Park, J.
    Kim, T.
    Meng, L.
    Lee, K. S.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26